Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BDX vs DBVT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BDX
Becton, Dickinson and Company

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$52.23B
5Y Perf.-3.1%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1669.52T
5Y Perf.-59.8%

BDX vs DBVT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BDX logoBDX
DBVT logoDBVT
IndustryMedical - Instruments & SuppliesBiotechnology
Market Cap$52.23B$1669.52T
Revenue (TTM)$21.92B$0.00
Net Income (TTM)$1.76B$-168M
Gross Margin45.8%
Operating Margin12.4%
Forward P/E11.5x
Total Debt$19.18B$22M
Cash & Equiv.$851M$194M

BDX vs DBVTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BDX
DBVT
StockMay 20May 26Return
Becton, Dickinson a… (BDX)10096.9-3.1%
DBV Technologies S.… (DBVT)10040.2-59.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: BDX vs DBVT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BDX leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. DBV Technologies S.A. is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
BDX
Becton, Dickinson and Company
The Income Pick

BDX carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.66, yield 2.9%
  • Rev growth 8.2%, EPS growth -0.5%, 3Y rev CAGR 5.0%
  • 72.0% 10Y total return vs DBVT's -87.1%
Best for: income & stability and growth exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT is the clearest fit if your priority is momentum.

  • +110.7% vs BDX's +43.1%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthBDX logoBDX8.2% revenue growth vs DBVT's -100.0%
Quality / MarginsBDX logoBDX8.0% margin vs DBVT's 0.3%
Stability / SafetyBDX logoBDXBeta 0.66 vs DBVT's 1.26
DividendsBDX logoBDX2.9% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.7% vs BDX's +43.1%
Efficiency (ROA)BDX logoBDX3.2% ROA vs DBVT's -89.0%

BDX vs DBVT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BDXBecton, Dickinson and Company
FY 2025
Medical
52.5%$11.5B
Interventional
23.9%$5.2B
Life Sciences
23.7%$5.2B
DBVTDBV Technologies S.A.

Segment breakdown not available.

BDX vs DBVT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDBVTLAGGINGBDX

Income & Cash Flow (Last 12 Months)

DBVT leads this category, winning 1 of 1 comparable metric.

BDX and DBVT operate at a comparable scale, with $21.9B and $0 in trailing revenue.

MetricBDX logoBDXBecton, Dickinson…DBVT logoDBVTDBV Technologies …
RevenueTrailing 12 months$21.9B$0
EBITDAEarnings before interest/tax$5.2B-$112M
Net IncomeAfter-tax profit$1.8B-$168M
Free Cash FlowCash after capex$2.6B-$151M
Gross MarginGross profit ÷ Revenue+45.8%
Operating MarginEBIT ÷ Revenue+12.4%
Net MarginNet income ÷ Revenue+8.0%
FCF MarginFCF ÷ Revenue+12.0%
Rev. Growth (YoY)Latest quarter vs prior year+1.6%
EPS Growth (YoY)Latest quarter vs prior year+28.8%+91.5%
DBVT leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

DBVT leads this category, winning 2 of 2 comparable metrics.
MetricBDX logoBDXBecton, Dickinson…DBVT logoDBVTDBV Technologies …
Market CapShares × price$52.2B$1669.52T
Enterprise ValueMkt cap + debt − cash$70.6B$1669.52T
Trailing P/EPrice ÷ TTM EPS24.73x-0.74x
Forward P/EPrice ÷ next-FY EPS est.11.54x
PEG RatioP/E ÷ EPS growth rate1.49x
EV / EBITDAEnterprise value multiple14.00x
Price / SalesMarket cap ÷ Revenue2.39x
Price / BookPrice ÷ Book value/share1.63x0.64x
Price / FCFMarket cap ÷ FCF19.56x
DBVT leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

BDX leads this category, winning 5 of 8 comparable metrics.

BDX delivers a 6.9% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-130 for DBVT. DBVT carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to BDX's 0.76x. On the Piotroski fundamental quality scale (0–9), BDX scores 7/9 vs DBVT's 4/9, reflecting strong financial health.

MetricBDX logoBDXBecton, Dickinson…DBVT logoDBVTDBV Technologies …
ROE (TTM)Return on equity+6.9%-130.2%
ROA (TTM)Return on assets+3.2%-89.0%
ROICReturn on invested capital+4.3%
ROCEReturn on capital employed+5.4%-145.7%
Piotroski ScoreFundamental quality 0–974
Debt / EquityFinancial leverage0.76x0.13x
Net DebtTotal debt minus cash$18.3B-$172M
Cash & Equiv.Liquid assets$851M$194M
Total DebtShort + long-term debt$19.2B$22M
Interest CoverageEBIT ÷ Interest expense4.65x-189.82x
BDX leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

DBVT leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in BDX five years ago would be worth $10,602 today (with dividends reinvested), compared to $3,041 for DBVT. Over the past 12 months, DBVT leads with a +110.7% total return vs BDX's +43.1%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs BDX's -0.6% — a key indicator of consistent wealth creation.

MetricBDX logoBDXBecton, Dickinson…DBVT logoDBVTDBV Technologies …
YTD ReturnYear-to-date-5.2%+2.3%
1-Year ReturnPast 12 months+43.1%+110.7%
3-Year ReturnCumulative with dividends-1.7%+18.1%
5-Year ReturnCumulative with dividends+6.0%-69.6%
10-Year ReturnCumulative with dividends+72.0%-87.1%
CAGR (3Y)Annualised 3-year return-0.6%+5.7%
DBVT leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BDX and DBVT each lead in 1 of 2 comparable metrics.

BDX is the less volatile stock with a 0.66 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBVT currently trades 74.4% from its 52-week high vs BDX's 70.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBDX logoBDXBecton, Dickinson…DBVT logoDBVTDBV Technologies …
Beta (5Y)Sensitivity to S&P 5000.66x1.26x
52-Week HighHighest price in past year$205.52$26.18
52-Week LowLowest price in past year$100.31$7.53
% of 52W HighCurrent price vs 52-week peak+70.1%+74.4%
RSI (14)Momentum oscillator 0–10033.343.7
Avg Volume (50D)Average daily shares traded2.5M249K
Evenly matched — BDX and DBVT each lead in 1 of 2 comparable metrics.

Analyst Outlook

BDX leads this category, winning 1 of 1 comparable metric.

Wall Street rates BDX as "Buy" and DBVT as "Buy". Consensus price targets imply 137.7% upside for DBVT (target: $46) vs 19.9% for BDX (target: $173). BDX is the only dividend payer here at 2.89% yield — a key consideration for income-focused portfolios.

MetricBDX logoBDXBecton, Dickinson…DBVT logoDBVTDBV Technologies …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$172.85$46.33
# AnalystsCovering analysts3315
Dividend YieldAnnual dividend ÷ price+2.9%
Dividend StreakConsecutive years of raises10
Dividend / ShareAnnual DPS$4.17
Buyback YieldShare repurchases ÷ mkt cap+1.9%0.0%
BDX leads this category, winning 1 of 1 comparable metric.
Key Takeaway

DBVT leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). BDX leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.

Best OverallDBV Technologies S.A. (DBVT)Leads 3 of 6 categories
Loading custom metrics...

BDX vs DBVT: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is BDX or DBVT a better buy right now?

Becton, Dickinson and Company (BDX) offers the better valuation at 24.

7x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Becton, Dickinson and Company (BDX) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — BDX or DBVT?

Over the past 5 years, Becton, Dickinson and Company (BDX) delivered a total return of +6.

0%, compared to -69. 6% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: BDX returned +72. 0% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — BDX or DBVT?

By beta (market sensitivity over 5 years), Becton, Dickinson and Company (BDX) is the lower-risk stock at 0.

66β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 91% more volatile than BDX relative to the S&P 500. On balance sheet safety, DBV Technologies S. A. (DBVT) carries a lower debt/equity ratio of 13% versus 76% for Becton, Dickinson and Company — giving it more financial flexibility in a downturn.

04

Which is growing faster — BDX or DBVT?

On earnings-per-share growth, the picture is similar: Becton, Dickinson and Company grew EPS -0.

5% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — BDX or DBVT?

Becton, Dickinson and Company (BDX) is the more profitable company, earning 7.

7% net margin versus 0. 0% for DBV Technologies S. A. — meaning it keeps 7. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BDX leads at 11. 8% versus 0. 0% for DBVT. At the gross margin level — before operating expenses — BDX leads at 45. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is BDX or DBVT more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 137.

7% to $46. 33.

07

Which pays a better dividend — BDX or DBVT?

In this comparison, BDX (2.

9% yield) pays a dividend. DBVT does not pay a meaningful dividend and should not be held primarily for income.

08

Is BDX or DBVT better for a retirement portfolio?

For long-horizon retirement investors, Becton, Dickinson and Company (BDX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

66), 2. 9% yield). Both have compounded well over 10 years (BDX: +72. 0%, DBVT: -87. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between BDX and DBVT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

BDX pays a dividend while DBVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BDX

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.